
Invitae Corporation NVTA
Quarterly report 2023-Q3
added 11-08-2023
Invitae Corporation Depreciation & Amortization 2011-2026 | NVTA
Annual Depreciation & Amortization Invitae Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 142 M | 80.5 M | 39 M | 16.2 M | 13.5 M | 9.18 M | 6.55 M | 5.32 M | 2.32 M | 928 K | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 142 M | 928 K | 31.6 M |
Quarterly Depreciation & Amortization Invitae Corporation
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.2 M | 5 M | 35 M | - | 9.7 M | 5.8 M | 27.1 M | - | 56.8 M | 35.3 M | 16.6 M | - | 23 M | 14.5 M | 6.06 M | - | 11.1 M | 6.72 M | 3.29 M | - | 10.3 M | 6.93 M | 3.43 M | - | 5.88 M | 3.49 M | 1.73 M | - | 4.93 M | 3.25 M | 1.56 M | - | 3.72 M | 2.3 M | 1.02 M | - | 1.57 M | 967 K | 471 K | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 56.8 M | 471 K | 10.4 M |
Depreciation & Amortization of other stocks in the Diagnostics research industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Akumin
AKU
|
98.2 M | - | -17.87 % | $ 25.9 M | ||
|
Agilent Technologies
A
|
321 M | $ 111.3 | -3.12 % | $ 33.8 B | ||
|
Castle Biosciences
CSTL
|
16 M | $ 24.24 | -1.86 % | $ 673 M | ||
|
Accelerate Diagnostics
AXDX
|
1.7 M | - | -61.36 % | $ 2.46 M | ||
|
Aspira Women's Health
AWH
|
112 K | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
1.66 M | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
2.55 M | - | 0.22 % | $ 16.8 M | ||
|
Neogen Corporation
NEOG
|
119 M | $ 9.01 | -3.53 % | $ 1.95 B | ||
|
Check-Cap Ltd.
CHEK
|
161 K | - | - | $ 9.42 M | ||
|
Co-Diagnostics
CODX
|
1.11 M | $ 1.53 | -6.13 % | $ 2.04 M | ||
|
Personalis
PSNL
|
10.9 M | $ 5.04 | -8.36 % | $ 299 M | ||
|
CareDx, Inc
CDNA
|
15 M | $ 20.8 | -5.07 % | $ 1.11 B | ||
|
DermTech
DMTK
|
200 K | - | -11.32 % | $ 2.94 M | ||
|
Enzo Biochem
ENZ
|
1.27 M | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
125 M | - | - | $ 19.8 B | ||
|
Fulgent Genetics
FLGT
|
24.9 M | $ 14.8 | -3.27 % | $ 447 M | ||
|
Illumina
ILMN
|
354 M | $ 120.37 | -5.16 % | $ 19.1 B | ||
|
Global Cord Blood Corporation
CO
|
43.3 M | - | - | $ 399 M | ||
|
Charles River Laboratories International
CRL
|
403 M | $ 163.84 | -1.77 % | $ 8.12 B | ||
|
HTG Molecular Diagnostics
HTGM
|
587 K | - | -20.0 % | $ 1.06 M | ||
|
Guardant Health
GH
|
39.7 M | $ 83.41 | 0.35 % | $ 10.5 B | ||
|
Twist Bioscience Corporation
TWST
|
24.9 M | $ 56.7 | -4.14 % | $ 3.39 B | ||
|
Lantheus Holdings
LNTH
|
70.1 M | $ 81.17 | -2.85 % | $ 5.48 B | ||
|
Heska Corporation
HSKA
|
14 M | - | - | $ 1.31 B | ||
|
Interpace Biosciences
IDXG
|
425 K | $ 1.99 | 2.9 % | $ 8.8 M | ||
|
Senseonics Holdings
SENS
|
1.51 M | $ 6.43 | -10.52 % | $ 268 M | ||
|
QIAGEN N.V.
QGEN
|
194 M | - | - | $ 10.6 B | ||
|
Medpace Holdings
MEDP
|
27.2 M | $ 413.59 | 0.93 % | $ 11.9 B | ||
|
Biomerica
BMRA
|
87 K | $ 2.16 | -1.22 % | $ 4.96 M | ||
|
Motus GI Holdings
MOTS
|
451 K | - | -34.28 % | $ 263 K | ||
|
ICON Public Limited Company
ICLR
|
488 M | $ 116.17 | 13.35 % | $ 9.58 B | ||
|
Laboratory Corporation of America Holdings
LH
|
681 M | $ 257.14 | -0.94 % | $ 21.4 B | ||
|
NeoGenomics
NEO
|
36.1 M | $ 8.96 | -0.67 % | $ 1.15 B | ||
|
Celcuity
CELC
|
167 K | $ 119.0 | -0.89 % | $ 5.56 B | ||
|
National Research Corporation
NRC
|
7.62 M | $ 16.54 | -1.78 % | $ 370 M | ||
|
Myriad Genetics
MYGN
|
53.7 M | $ 4.68 | -3.31 % | $ 433 M | ||
|
Natera
NTRA
|
16.7 M | $ 194.75 | -2.71 % | $ 19.2 B | ||
|
Quest Diagnostics Incorporated
DGX
|
570 M | $ 189.32 | -2.94 % | $ 21 B | ||
|
Burning Rock Biotech Limited
BNR
|
47.8 M | $ 16.24 | -2.46 % | $ 175 M | ||
|
OpGen
OPGN
|
175 K | - | -16.95 % | $ 1.54 M | ||
|
Organovo Holdings
ONVO
|
266 K | - | -2.3 % | $ 19.4 M |